Rischin D, Brungs D, Day F, Christie H, Patel V, Adams G, Estes Jackson J, De Liz Vassen Schurmann M, Kirtbaya D, Shin T, Hart C, Stankevich E, Li S, Lowy I, Han H, Gonçalves P, Fury M, Porceddu S. C-POST protocol update: A Phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s173. Available from: https://jofskin.org/33014/index.php/skin/article/view/1996